During II/R, Nrf2 and STAT3 jointly upregulate the expression of SLC7A11 and HO-1 and inhibit ferroptosis, thus reducing II/R-induced ALI and providing a new scheme for targeting the Nrf2 pathway in the treatment of II/R-induced ALI [69]. The gene discussed is STAT3; the disease is acute respiratory distress syndrome.